ما هو علاج التهاب العصب البصري؟ نهج الكورتيكوستيرويد الوريدي في الخط الأول

References

DOI: 10.4103/0301-4738.77020

The patients were randomized into 3 different treatment groups: oral placebo for 14 days; intravenous methylprednisolone (250 mg, 6 hourly) for 3 days, followed by oral prednisolone (1 mg\kg\d) for 11 days and a 3-day tapering of prednisolone thereafter; oral prednisolone (1 mg\kg\d) for 14 days, followed by a 3-day tapering.

At our center, we routinely use 200 mg intravenous dexamethasone for 3 days, followed by oral prednisolone.

Treatment with oral prednisolone in conventional doses alone, is contraindicated.

More than 90% of the patients recover a visual acuity of 20/40 or better by 6 months, as seen in the ONTT.